Robert Pelley
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 9
- Pancreatic and Hepatic Oncology Research 8
- Lung Cancer Research Studies 5
- Colorectal Cancer Surgical Treatments 4
- Parasitology top 5%
- Otorhinolaryngology top 5%
-
- Colorectal and Anal Carcinomas 5
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Allan SipersteinEren BerberMark E. BakerH J KungHui‐Kuo G. ShuRonald M. BukowskiKenneth S. WarrenRonald P. Pelley
- Cited by
- HepatologyOncologyParasitology
- Journals
- Journal of Clinical Oncology (9 papers)Cancer (5 papers)Investigational New Drugs (3 papers)
- Partner nations
- United StatesChileAustralia
In The Last Decade
Robert Pelley
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Hepatology 318
- Oncology 716
- Parasitology 102
- Otorhinolaryngology 67
- Pulmonary and Respiratory Medicine 447
Countries citing papers authored by Robert Pelley
This map shows the geographic impact of Robert Pelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pelley more than expected).
Fields of papers citing papers by Robert Pelley
This network shows the impact of papers produced by Robert Pelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pelley. The network helps show where Robert Pelley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Pelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 63 | |
| 2 | 2011 | 22 | |
| 3 | 2010 | 19 | |
| 4 | 2010 | 27 | |
| 5 | 2008 | 11 | |
| 6 | 2008 | 12 | |
| 7 | 2008 | 57 | |
| 8 | 2006 | 17 | |
| 9 | 2006 | 15 | |
| 10 | 2002 | 9 | |
| 11 | 2001 | 30 | |
| 12 | 2000 | 5 | |
| 13 | 2000 | 35 | |
| 14 | 1999 | 29 | |
| 15 | 1995 | 83 | |
| 16 | 1994 | 11 | |
| 17 | 1994 | 16 | |
| 18 | 1993 | 126 | |
| 19 | 1990 | 45 | |
| 20 | Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow. | 1985 | 61 |
About Robert Pelley
Robert Pelley is a scholar working on Oncology, Hepatology, Parasitology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal and Anal Carcinomas (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). The work is most often cited by research in Hepatology (318 citations), Oncology (716 citations), Parasitology (102 citations), Otorhinolaryngology (67 citations) and Pulmonary and Respiratory Medicine (447 citations). Robert Pelley has collaborated with scholars based in United States, Chile and Australia. Frequent co-authors include Allan Siperstein, Eren Berber, Mark E. Baker, H J Kung, Hui‐Kuo G. Shu, Ronald M. Bukowski, Kenneth S. Warren, Ronald P. Pelley, Joseph Hamburger and Pierre Peters. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Investigational New Drugs, Journal of Virology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.